Search
for

    Sort by

    Research 30 of 184

    1. Cancer Treatments and Alopecia: A Systematic Review Turkiye Klinikleri Journal of Internal Medicine · 2021 · 2 citations
    2. Topoisomerase‐Interacting Agents 2013 · 2 citations
    3. Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies Refubium (Universitätsbibliothek der Freien Universität Berlin) · 2016
    4. Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer Oncology Reviews · 2026
    5. Clinical Development of Topoisomerase-Interactive Drugs Advances in pharmacology · 1994 · 10 citations
    6. Sacituzumab Govitecan-Hziy (Trodelvy™) Oncology Times · 2021 · 3 citations
    7. Adverse effects of common medications on male fertility Nature Reviews Urology · 2015 · 77 citations
    8. Dermatologic Adverse Events from Cancer Treatments Springer eBooks · 2018 · 2 citations
    9. Cutaneous Side Effects of Chemotherapy and Radiotherapy 2016 · 2 citations
    10. Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia PLoS ONE · 2013 · 20 citations
    11. Enzyme Inhibitors from Gorgonians and Soft Corals Marine Drugs · 2023 · 4 citations
    12. Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia European Journal of Pharmacology · 2001 · 28 citations
    13. Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia Open Repository of the University of Porto (University of Porto) · 2024
    14. An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy Nanomaterials · 2023 · 1 citations
    15. General Dermatology Springer eBooks · 2017
    16. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro Drug Design Development and Therapy · 2015 · 12 citations
    17. Pharmacotherapy for Keloids and Hypertrophic Scars International journal of molecular sciences · 2024
    18. Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital Anais Brasileiros de Dermatologia · 2021 · 7 citations
    19. Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers Experimental dermatology · 2022 · 7 citations
    20. Referee report. For: Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment [version 3; peer review: 2 approved] Faculty of 1000 Research Ltd · 2021
    21. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment F1000Research · 2021 · 1 citations
    22. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment F1000Research · 2021
    23. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment F1000Research · 2021 · 8 citations
    24. Repurposing of approved cardiovascular drugs Journal of Translational Medicine · 2016 · 73 citations
    25. Medications Springer eBooks · 2016
    26. Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer Journal of thoracic oncology · 2010 · 12 citations
    27. Protein degradation: expanding the toolbox to restrain cancer drug resistance Journal of Hematology & Oncology · 2023 · 7 citations
    28. Pathobiology of chemotherapy-induced hair loss The Lancet Oncology · 2013 · 218 citations
    29. Chemotherapy‐induced alopecia management: Clinical experience and practical advice Journal of Cosmetic Dermatology · 2017 · 48 citations
    30. Hair Changes due to Drugs Elsevier eBooks · 2018